Search clinical trials for: alendronate

Total 189 results

Organon and Co

Completed

A Study and 12 Month Extension to Evaluate Two Investigational Drugs in Postmenopausal Women With Osteoporosis (MK-0217-907)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)

Osteoporosis
Organon and Co

Completed

A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED)

Osteoporosis, Postmenopausal
Organon and Co

Completed

FOSAMAX PLUS and FOSAMAX PLUS D Re-examination Study (0217A-267)

Osteoporosis
Organon and Co

Completed

FLEX - Long-term Extension of FIT (Fracture Intervention Trial)(0217-051)

Osteoporosis, Postmenopausal
Organon and Co
World Health Information Science Consultants, LLC

Completed

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Adenocarcinoma | Esophageal Cancer | Squamous Cell Carcinoma
Organon and Co

Completed

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Osteoporosis, Postmenopausal
Organon and Co

Completed

A Research Study to Test the Effectiveness of MK0217 in Patients With Paget's Bone Disease (0217-206)(COMPLETED)

Paget's Disease of Bone
Organon and Co

Completed

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

Osteoporosis
Organon and Co

Completed

A Study to Evaluate the Safety, Tolerability, and Efficacy of an Investigational Drug and Dietary Supplement in Men and Postmenopausal Women With Osteoporosis (0217A-227)

Vitamin D Deficiency | Osteoporosis
Xinhua Hospital, Shanghai Jiao Tong University...

Completed

99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis

Osteoporosis | Differentiated Thyroid Cancer

China
Ain Shams University
Nahda University

Completed

Alendronate Versus Denosumab in Kidney Transplant Patients

Osteoporosis, Osteopenia | Renal Transplant Recipient

Egypt
National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents

HIV Infection

Puerto Rico, United States, Brazil
University of Edinburgh
NHS Lothian; British Heart Foundation

Completed

Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis. (SALTIRE II)

Calcific Aortic Stenosis

United Kingdom
Mahidol University

Completed

Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment

Osteoporosis

Thailand
Nancy E. Lane, MD
California Institute for Regenerative Medicine (CIRM)

Completed

Safety and Tolerability of Intravenous LLP2A-Alendronate for Osteopenia Secondary to Glucocorticoids

Osteoporosis | Osteonecrosis | Osteopenia

United States
Aarhus University Hospital
University of Aarhus

Completed

Predictive Value of Bone Turnover Markers During Discontinuation With Alendronate (PROSA)

Osteoporosis

Denmark
Radius Health, Inc.

Completed

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis (ACTIVExtend)

Postmenopausal Osteoporosis

Poland, Hong Kong, Romania, Estonia, United States, Argentina, Brazil, Denmark, Lithuania, Czechia
Labatec Pharma SA

Unknown

Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes

Osteoporosis, Postmenopausal

Switzerland
University of Wisconsin, Madison
Wisconsin Partnership Program

Terminated

Pilot Study of Bisphosphonates for Breast Cancer

Breast Neoplasms

United States
Johns Hopkins University

Terminated

Stem Cell Recruitment in Osteoporosis Therapy

Low Bone Density

United States
Amgen

Completed

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Osteoporosis
NCIC Clinical Trials Group
National Cancer Institute (NCI); Southwest Oncology Group; North Central Cancer...

Completed

Bone Mineral Density in Postmenopausal Women With Primary Breast Cancer Who Are Receiving Treatment on Clinical Trial

Breast Cancer | Osteoporosis

Canada
Tuen Mun Hospital

Completed

Denosumab Versus Bisphosphonates (Alendronate) in GIOP

Osteoporosis

China
Hebrew SeniorLife
GlaxoSmithKline; Merck Sharp & Dohme LLC; National Institute on Aging (NIA)

Completed

Secondary Prevention of Osteoporosis

Osteoporosis

United States
Amgen

Completed

Denosumab Adherence Preference Satisfaction Study

Osteoporosis
University of Baghdad

Unknown

Efficacy of Antiresorptive and Bone Forming Material on Dental Implants

Partial Edentulism

Iraq
Islamic Azad University, Tehran

Completed

Evaluation, the Histomorphometric Study of Nanocrystalline Hydroxyapatite (Nano Bone) Wif Alendronate in the Preservation of the Tooth Socket

Bone Resorption

Iran, Islamic Republic of
Amgen

Completed

Transition From Alendronate to Romosozumab (AMG 785)

Osteoporosis

United States
Yuyu Pharma, Inc.

Completed

Pharmacokinetics of Maxmarvil® in Healthy Postmenopausal Women (YY_PK_2011)

Osteoporosis

Korea, Republic of
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield

Completed

Resolution of Effect of Bisphosphonates on Bone in Postmenopausal Osteoporosis

Postmenopausal Osteoporosis

United Kingdom
Evangelisches Krankenhaus Lutherhaus gGmbH
German Federal Ministry of Education and Research

Terminated

Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy (BILANZ)

Osteoporosis

Germany
Taichung Veterans General Hospital

Unknown

Osteoporosis Treatment in Post-menopausal Women

Depressive Syndrome

Taiwan
Nanfang Hospital of Southern Medical University

Active, not recruiting

Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

Quality of Life | Osteoporosis, Postmenopausal | Vertebral Fracture
University of Chicago
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Completed

Texture Analysis for Postmenopausal Osteoporosis

Osteoporosis | Osteopenia

United States
Columbia University
Novartis Pharmaceuticals

Completed

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation (CTX)

Liver Transplantation | Heart Transplantation | Bone Resorption

United States
Medical University of South Carolina
Merck Sharp & Dohme LLC; FDA Office of Orphan Products Development

Completed

Alendronate in Juvenile Osteoporosis

Fractures | Juvenile Osteoporosis | Low Bone Density

United States
Fujian Cancer Hospital

Unknown

Appaconitine Patch for Oral Mucositis Pain Caused by Chemoradiotherapy in Patients With Nasopharyngeal Cancer

Radiation Induced Oral Mucositis

China
Unity Health Toronto
CIHR Canadian HIV Trials Network

Completed

Bone Antiresorptive Therapy With Antiretroviral Initiation (BATARI) Pilot Trial (BATARI)

HIV

Canada
Assistance Publique - Hôpitaux de Paris

Completed

Bone Healing After Dental Extraction in Postmenopausal Osteoporotic Women Treated With Alendronate Per os Weekly (BOCOMEDEN)

Alveolar Bone Healing After Dental Extraction

France
Sheffield Teaching Hospitals NHS Foundation Trust
University of Sheffield; Procter and Gamble

Completed

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Post-menopausal Osteoporosis

United Kingdom
Milton S. Hershey Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Alendronate to Prevent Loss of Bronchoprotection in Asthma (ALFA)

Asthma

United States
BIOrest Ltd.

Unknown

BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY (BLADE)

Diabetes Mellitus

Israel
Gilles Boire
Procter and Gamble

Completed

Assessment of Response to Treatment of Osteoporosis With Oral Bisphosphonates in Patients With Muscular Dystrophy

Muscular Dystrophy | Osteoporosis | Cystic Fibrosis

Canada
GlaxoSmithKline

Terminated

A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis.

Osteoporosis

Germany, Russian Federation, Korea, Republic of, United States, Belgium, Hong Kong, Spain, Australia, Argentina, South Africa, Poland, Norway, Mexico, Denmark
Helen Hayes Hospital
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Unknown

Cyclic Versus Daily Teriparatide on Bone Mass

Osteoporosis

United States
National Institute of Dental and Craniofacial Research...

Completed

Alendronate to Treat Polyostotic Fibrous Dysplasia and McCune-Albright Syndrome

Polyostotic Fibrous Dysplasia

United States
National Institute of Mental Health (NIMH)

Completed

Bone Loss in Premenopausal Women With Depression

Depression | Healthy | Osteoporosis | Osteopenia

United States
Government Dental College and Research Institute...

Completed

Local Host Modulating Agents Alendronate & Aloe Vera for Treatment of Furcation Defects in Chronic Periodontitis

Chronic Periodontitis
Indiana University School of Medicine

Completed

Bisphosphonate Therapy for Osteogenesis Imperfecta

Osteoporosis | Osteogenesis Imperfecta | Paget Disease of Bone

Search clinical trials for: alendronate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations